On Jul. 28, 2020, scientists at the National Institute of Allergy and Infectious Diseases reported that two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2, the virus that causes COVID-19.